drugset / Trial / NCT04618328
A Study of ATRA in the Treatment of ITP
Phase 2
Unknown
80 enrolled
Peking University People's Hospital
Beijing Hospital · collabNavy General Hospital, Beijing · collabQilu Hospital of Shandong University · collab
NaSingle-groupOpen-labelTreatment
Summary
An open-label, multicenter study to compare the efficacy and safety of ATRA for the treatment of adults with primary immune thrombocytopenia (ITP)
Timeline
- Start
- 2020-11
- Primary completion
- 2021-10
- Completion
- 2021-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tretinoin | Small molecule | 10 mg | Oral |